-
1
-
-
0023808730
-
Plasmid-mediated resistance to vancomycin and teicoplanin in enterococcus faecium
-
Leclercq R, Derlot E, Duval J, et al. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med. 1988;319(3):157-161.
-
(1988)
N Engl J Med
, vol.319
, Issue.3
, pp. 157-161
-
-
Leclercq, R.1
Derlot, E.2
Duval, J.3
-
2
-
-
0023837814
-
Vancomycin- resistant enterococci
-
Uttley AH, Woodford N, Johnson AP, et al. Vancomycin- Resistant Enterococci. Lancet. 1988;1(8575-6):57-58.
-
(1988)
Lancet
, vol.1
, Issue.8575-8576
, pp. 57-58
-
-
Uttley, A.H.1
Woodford, N.2
Johnson, A.P.3
-
4
-
-
0037190708
-
Health and economic outcomes of vancomycin-resistant enterococci
-
Carmeli Y, Eliopoulos G, Mozaffari E, et al. Health and economic outcomes of vancomycin-resistant enterococci. Arch Intern Med. 2002;162:2223-2228.
-
(2002)
Arch Intern Med
, vol.162
, pp. 2223-2228
-
-
Carmeli, Y.1
Eliopoulos, G.2
Mozaffari, E.3
-
5
-
-
0141869007
-
Outcomes associated with vancomycin-resistant enterococci: A meta-analysis
-
Saldago CD, Farr BM. Outcomes associated with vancomycin-resistant enterococci: A meta-analysis. Infect Control Hosp Epidemiol. 2003;24(9):690-698.
-
(2003)
Infect Control Hosp Epidemiol
, vol.24
, Issue.9
, pp. 690-698
-
-
Saldago, C.D.1
Farr, B.M.2
-
6
-
-
49549094298
-
The burden of vancomycin-resistant enterococcal infections in us hospitals, 2003 to 2004
-
Reik R, Tenover FC, Klein E, et al. The burden of vancomycin-resistant enterococcal infections in US hospitals, 2003 to 2004. Diagn Microbiol Infect Dis. 2008;62:81-85.
-
(2008)
Diagn Microbiol Infect Dis
, vol.62
, pp. 81-85
-
-
Reik, R.1
Tenover, F.C.2
Klein, E.3
-
7
-
-
0003184226
-
-
Sep 22, (RR-12)
-
MMWR Recomm Rep. 1995 Sep 22;44(RR-12):1-13.
-
(1995)
MMWR Recomm Rep
, vol.44
, pp. 1-13
-
-
-
9
-
-
0031925669
-
Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: Comparison of clinical features and outcomes
-
Lucus GM, Lechtzin N, Puryear D, et al. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. Clin Infect Dis. 1998;26:1127-1133.
-
(1998)
Clin Infect Dis
, vol.26
, pp. 1127-1133
-
-
Lucus, G.M.1
Lechtzin, N.2
Puryear, D.3
-
10
-
-
0033128729
-
Enterococcal bacteremia: Risk factors for vancomycin resistance and predictors of mortality
-
Lautenbach E, Bilker WB, Brennan PJ. Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality. Infect Control Hosp Epidemiol. 1999;20:318-323.
-
(1999)
Infect Control Hosp Epidemiol
, vol.20
, pp. 318-323
-
-
Lautenbach, E.1
Bilker, W.B.2
Brennan, P.J.3
-
11
-
-
77249176077
-
Outcomes of invasive infection due to vancomycin-resistant enterococcus faecium during a recent outbreak
-
Theilacker C, Jonas D, Huebner J, et al. Outcomes of invasive infection due to vancomycin-resistant Enterococcus faecium during a recent outbreak. Infection. 2009;37:540-543.
-
(2009)
Infection
, vol.37
, pp. 540-543
-
-
Theilacker, C.1
Jonas, D.2
Huebner, J.3
-
12
-
-
42549108292
-
Risk of vancomycin-resistant enterococcus (vre) bloodstream infection among patients colonized with vre
-
Olivier CN, Blake RK, Steed LL, et al. Risk of vancomycin-resistant enterococcus (VRE) bloodstream infection among patients colonized with VRE. Infect Control Hosp Epidemiol. 2008;29:404-409.
-
(2008)
Infect Control Hosp Epidemiol
, vol.29
, pp. 404-409
-
-
Olivier, C.N.1
Blake, R.K.2
Steed, L.L.3
-
13
-
-
78651508828
-
Incidence of vancomycin-resistant enterococci (vre) infection in high-risk febrile neutropenic patients colonized with vre
-
E-pub Jan 13, 2010
-
Bossaer JB, Hall PD, Garrett-Mayer E. Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE. Support Care Cancer. 2010;19(2):231-237. E-pub Jan 13, 2010.
-
(2010)
Support Care Cancer
, vol.19
, Issue.2
, pp. 231-237
-
-
Bossaer, J.B.1
Hall, P.D.2
Garrett-Mayer, E.3
-
14
-
-
77957753370
-
The changing epidemiology of vancomycin-resistant enterococcus (vre) bacteremia in allogeneic hematopoietic stem cell transplant (hsct) recipients
-
E-pub May 26, 2010
-
Kamboj M, Chung D, Seo SK, et al. The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Biol Blood Marrow Transplant. 2010;16(11):1576-1581. E-pub May 26, 2010.
-
(2010)
Biol Blood Marrow Transplant
, vol.16
, Issue.11
, pp. 1576-1581
-
-
Kamboj, M.1
Chung, D.2
Seo, S.K.3
-
15
-
-
0036189636
-
Risk factors for vancomycin-resistant enterococcus (vre) infection in colonized patients with cancer
-
Husni R, Hachem R, Hanna H, et al. Risk factors for vancomycin-resistant Enterococcus (VRE) infection in colonized patients with cancer. Infect Control Hosp Epidemiol. 2002;23:102-103.
-
(2002)
Infect Control Hosp Epidemiol
, vol.23
, pp. 102-103
-
-
Husni, R.1
Hachem, R.2
Hanna, H.3
-
16
-
-
0030831050
-
Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (vre) in vre-colonized patients with acute leukemia
-
Roghmann MC, McCarter RJ Jr, Brewrink J, et al. Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemia. Clin Infect Dis. 1997;25:1056-1059.
-
(1997)
Clin Infect Dis
, vol.25
, pp. 1056-1059
-
-
Roghmann, M.C.1
Mccarter Jr., R.J.2
Brewrink, J.3
-
17
-
-
34547817285
-
Vancomycin-resistant enterococcus faecium in patients with hematologic malignancy: Patients with acute myeloid leukemia are at high-risk
-
Worth LJ, Thursky KA, Seymour JF, et al. Vancomycin-resistant Enterococcus faecium in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk. Eur J Haematol. 2007;79:226-233.
-
(2007)
Eur J Haematol
, vol.79
, pp. 226-233
-
-
Worth, L.J.1
Thursky, K.A.2
Seymour, J.F.3
-
18
-
-
22544433208
-
Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptibility enterococcal bloodstream infections: A meta-analysis
-
DiazGranados CA, Zimmer SM, Klein M, et al. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptibility enterococcal bloodstream infections: A meta-analysis. Clin Infect Dis. 2005;41:327-333.
-
(2005)
Clin Infect Dis
, vol.41
, pp. 327-333
-
-
Diazgranados, C.A.1
Zimmer, S.M.2
Klein, M.3
-
19
-
-
40249117000
-
Vancomycin-resistant enterococcal colonization appears associated with increased mortality among allogeneic hematopoietic stem cell transplant recipients
-
Zirakzadeh A, Gastineau DA, Mandrekar JN, et al. Vancomycin-resistant enterococcal colonization appears associated with increased mortality among allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 2008;41:385-392.
-
(2008)
Bone Marrow Transplant
, vol.41
, pp. 385-392
-
-
Zirakzadeh, A.1
Gastineau, D.A.2
Mandrekar, J.N.3
-
20
-
-
13444288108
-
Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection
-
DiazGranados C, Jernigan J. Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection. J Infect Dis. 2005;191:588-595.
-
(2005)
J Infect Dis
, vol.191
, pp. 588-595
-
-
Diazgranados, C.1
Jernigan, J.2
-
21
-
-
34248360771
-
Daptomycin in the treatment of vancomycin-resistant enterococcus faecium bacteremia in neutropenic patients
-
Poutsiaka DD, Skiffington S, Miller KB, et al. Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients. J Infect. 2007;54:567-571.
-
(2007)
J Infect
, vol.54
, pp. 567-571
-
-
Poutsiaka, D.D.1
Skiffington, S.2
Miller, K.B.3
-
22
-
-
34247148461
-
Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogenic hematopoietic stem cell transplant
-
Weinstock DM, Conlon M, Iovino C, et al. Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogenic hematopoietic stem cell transplant. Biol Blood Marrow Transplant. 2007;13:615-621.
-
(2007)
Biol Blood Marrow Transplant
, vol.13
, pp. 615-621
-
-
Weinstock, D.M.1
Conlon, M.2
Iovino, C.3
-
23
-
-
83555172636
-
Outcomes of therapy: Vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients
-
E-pub 2010 Nov 26, 2010
-
Kraft S, Mackler E, Schlickman P, et al. Outcomes of therapy: vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients. Support Care Cancer. 2011;19(12):1969-1974. E-pub 2010 Nov 26, 2010.
-
(2011)
Support Care Cancer
, vol.19
, Issue.12
, pp. 1969-1974
-
-
Kraft, S.1
Mackler, E.2
Schlickman, P.3
-
24
-
-
84857795628
-
Vancomycin-resistant enterococcus bacteremia: An evaluation of treatment with linezolid or daptomycin
-
doi: 10.1002/jhm.994. E-pub 2011 Nov 10, 2011
-
Twilla JD, Finch CK, Usery JB, et al. Vancomycin-resistant Enterococcus bacteremia: An evaluation of treatment with linezolid or daptomycin. J Hosp Med. 2012;7(3):243-248. doi: 10.1002/jhm.994. E-pub 2011 Nov 10, 2011.
-
(2012)
J Hosp Med
, vol.7
, Issue.3
, pp. 243-248
-
-
Twilla, J.D.1
Finch, C.K.2
Usery, J.B.3
-
25
-
-
0037767160
-
Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant gram-positive infections in cancer patients with neutropenia
-
Smith PF, Birmingham MC, Noskin GA, et al. Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant gram-positive infections in cancer patients with neutropenia. Ann Oncol. 2003;14:795-801.
-
(2003)
Ann Oncol
, vol.14
, pp. 795-801
-
-
Smith, P.F.1
Birmingham, M.C.2
Noskin, G.A.3
-
26
-
-
33144464478
-
Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer
-
Jaksic B, Martinelli G, Perez-Oteyza J, et al. Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer. Clin Infect Dis. 2006;42:597-607.
-
(2006)
Clin Infect Dis
, vol.42
, pp. 597-607
-
-
Jaksic, B.1
Martinelli, G.2
Perez-Oteyza, J.3
-
27
-
-
80051676875
-
Vancomycin-resistant enterococcal bacteraemia and daptomycin: Are higher doses necessary?
-
E-pub Jun 22, 2011
-
King EA, McCoy D, Desai S, et al. Vancomycin-resistant enterococcal bacteraemia and daptomycin: Are higher doses necessary? J Antimicrob Chemother. 2011;66(9):2112-2118. E-pub Jun 22, 2011.
-
(2011)
J Antimicrob Chemother
, vol.66
, Issue.9
, pp. 2112-2118
-
-
King, E.A.1
McCoy, D.2
Desai, S.3
-
28
-
-
39349084481
-
Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant enterococcus bacteremia
-
Erlandson KM, Sun J, Iwen PC, et al. Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant Enterococcus bacteremia. Clin Infect Dis. 2008;46:30-36.
-
(2008)
Clin Infect Dis
, vol.46
, pp. 30-36
-
-
Erlandson, K.M.1
Sun, J.2
Iwen, P.C.3
-
29
-
-
61349182487
-
Vancomycin-resistant enterococci bacteremia: Risk factors for mortality and influence of antimicrobial therapy on clinical outcome
-
Han SH, Chin BS, Lee HS, et al. Vancomycin-resistant enterococci bacteremia: risk factors for mortality and influence of antimicrobial therapy on clinical outcome. J Infect. 2009;58:182-190.
-
(2009)
J Infect
, vol.58
, pp. 182-190
-
-
Han, S.H.1
Chin, B.S.2
Lee, H.S.3
-
30
-
-
38049141184
-
Compliance with a critical pathway for the management of febrile neutropenia and impact on clinical outcomes
-
Zuckermann J, Moreira LB, Stoll P, et al. Compliance with a critical pathway for the management of febrile neutropenia and impact on clinical outcomes. Ann Hematol. 2008;87(2):139.
-
(2008)
Ann Hematol
, vol.87
, Issue.2
, pp. 139
-
-
Zuckermann, J.1
Moreira, L.B.2
Stoll, P.3
-
31
-
-
0242266613
-
Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis
-
Harbarth S, Garbino J, Pugin J, et al. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med. 2003;115(7):529-535.
-
(2003)
Am J Med
, vol.115
, Issue.7
, pp. 529-535
-
-
Harbarth, S.1
Garbino, J.2
Pugin, J.3
-
32
-
-
37549020378
-
Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2008
-
Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36(1):296-327.
-
(2008)
Crit Care Med
, vol.36
, Issue.1
, pp. 296-327
-
-
Dellinger, R.P.1
Levy, M.M.2
Carlet, J.M.3
-
33
-
-
70350463588
-
Effectiveness of treatments for severe sepsis: A prospective multicenter observational study
-
Ferrer R, Artigas A, Suarez D, et al. Effectiveness of treatments for severe sepsis: A prospective multicenter observational study. Am J Respir Crit Care Med. 2009;180(9):861-866.
-
(2009)
Am J Respir Crit Care Med
, vol.180
, Issue.9
, pp. 861-866
-
-
Ferrer, R.1
Artigas, A.2
Suarez, D.3
-
34
-
-
79951816939
-
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america
-
Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52(4):427-431.
-
(2011)
Clin Infect Dis
, vol.52
, Issue.4
, pp. 427-431
-
-
Freifeld, A.G.1
Bow, E.J.2
Sepkowitz, K.A.3
|